Letters, Testimony & Comments

A concerted effort through the TTIP to unleash the potential of biotechnology in the Transatlantic economy and beyond will go a long way...
June 19 2013
Introduction The Biotechnology Industry Organization (BIO) appreciates the opportunity to respond to the Request for Comments issued by...
June 3 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 8 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
January 18 2013
Draft Guidelines Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in...
November 28 2012
The Biotechnology Industry Organization (BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR...
November 8 2012
BIO supports the President’s decision to include Mexico in the TPP trade negotiations. Providing effective intellectual property...
September 5 2012
I. Agricultural and Animal Biotechnology The Government of Canada has long been a trusted ally to the United States on agricultural...
September 4 2012
The Biotechnology Industry Organization (BIO) appreciates the U.S. Trade Representative's (USTR) query about BIO's views on how...
August 17 2012
The United States Patent and Trademark Office (USPTO) has led the world in providing technical expertise and training to various patent...
July 26 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to enhance...
June 28 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 26 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
By Electronic Submission Ip.policy@uspto.gov Office of Policy and External Affairs United States Patent and Trademark Office...
November 10 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
October 27 2011
By electronic submission   Mr. Stan McCoy Assistant USTR for Intellectual Property and Innovation Office of the U.S. Trade...
October 20 2011
Dear Secretary Locke: On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
May 13 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations Dear Ms. Blue: The Biotechnology Industry...
November 22 2010
October 14, 2010 To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data...
July 26 2010
Intellectual Property Innovation and Chair of the Special 301 Committee Office of the United States Trade Representative Washington, D...
February 18 2010
Dear Ms. Blue, This letter is submitted by the Biotechnology Industry Organization (BIO) in response to the request for public comment...
November 3 2009
  VIEWS AND PROPOSALS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF...
July 31 2009
U.S. Department of State
June 1 2009
Re: Docket No. FDA-2009-D-0675, OC 20091. Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug...
April 13 2009
Office of the U.S. Trade Representative
March 11 2009
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (...
February 11 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
Office of the U.S. Trade Representative
March 8 2007
Office of the U.S. Trade Representative
September 18 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
Letter to USTR on continuing concerns.
March 31 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24 2006
February 11 2005
Re: Docket No. 2004N-0115 Request for Comment on Prescription Drug Importation Dear Dr. Carmona and Members of the HHS Task Force on...
June 1 2004
TESTIMONY OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION BEFORE THE COMMITTEE ON HEALTH, EDUCATION, LABOR, & PENSIONS OF THE...
May 20 2004
April 14, 2004, 9:00 a.m. -5:00 p.m. Natcher Auditorium, Building 45, National Institutes of Health (NIH) 9000 Rockville Pike,...
April 14 2004
February 13 2004
The Honorable J. Dennis Hastert 235 Cannon House Office Building U.S. House of Representatives Washington DC 20510 Dear Speaker...
July 15 2003
The Honorable Mark B. McClellan Commissioner United States Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,...
February 14 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 29 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
November 27 2002
Every Year... -of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries Introduction: -...
National Institutes of Health: An International Perspective NIH Mission: To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT...
July 10 2013
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a knowledge-intensive economy.
June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  
June 3 2013
BIO appreciates the opportunity to respond to the Request for Comments issued by the U.S. Trade Representative on objectives to be pursued in the negotiation of a Transatlantic Trade and Investment Partnership (TTIP) agreement. 
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has developed and commercialized more than 300 biotechnology drugs and diagnostics and there are over 400 products in the pipeline.
January 18 2013
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments in response to the Controller General of Patents Designs and Trademarks in India on the "Draft Guidelines for Examination of Biotechnology Applications" hereafter referred to as "Draft Guidelines", or "Guidelines".
June 20 2012
The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.
June 6 2012
The report will be released at a Super Session, titled "International Leaders Share Their Worldview: Scientific American's Regional Bio-Innovation Scorecard."
February 21 2011
The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.
April 6 2010
The Obama Administration has made substantial progress to avoid retaliatory measures in a long-running “cotton dispute” brought by Brazil against the United States.
March 2 2010
The Biotechnology Industry Organization (BIO) applauded today’s announcement by the European Commission to authorize the cultivation of a biotech potato, as well as the commercialization of three varieties of biotech maize for food and feed uses and import and processing.